Abstract:Objective To explore the prevalence of SLC25A13 gene mutations in Chinese infants with intrahepatic cholestasis and to understand the clinical presentation,laboratory biochemistry and blood amino acids features of patients with mutations.Methods Blood amino acids were analyzed by using mass chromatography in 115 infants who were referred to our hospital for further investigations of intrahepatic cholestasis from December 2003 to December 2006. All exons and their neighbouring sequences of SLC25A13 gene were analysed in children whose plasma citrulline obviously elevated. Two most common mutations of SLC25A13 gene, 851del4 and 1638ins23 were screened in children without obvious citrullinemia. Mutation 851del4 was detected by real-time fluorescent quantitation PCR with double labelling probes, and mutation 1638ins23 was detected by electrophoresis of PCR product directly. If the children in whom only one heterozygous mutation was found, all exons and nearby sequences were analysed then after. Clinical presentation,laboratory biochemistry and blood amino acids examinations were analyzed.Results SLC25A13 gene mutations were found in 4 of 5 children with citrullinemia, including 1 patient with homozygous mutation 851del4/851del4, 1 patient with compound heterozygous mutation 851del4/1638ins23, and 2 patients with heterozygous mutation 851del4. SLC25A13 gene mutations were also found in 6 cases of the other 110 intrahepatic cholestasis patients, including 1 patient with homozygous mutation 851del4/851del4, 1 patient with compound heterozygous mutation 851del4/1638ins23, and 4 patients with heterozygous mutation 851del4. Totally, SLC25A13 gene mutations were detected in 10 of the 115 intrahepatic cholestasis patients. The prevalence rate was 8.7%. Liver biopsy was done in 7 of 10 children with SLC25A13 gene mutations, and significant steatosis was found in 4 of them. Laboratory biochemistry changes included obviously elevation of bilirubin,γ-glutamyl transpeptidase and alkaline phosphatase. The elevation of aspartate aminotransferase was more obvious than alanine aminotransferase. Characteristic amino acids such as citrulin,threonine and methionine elevation was found in 5 children with mutations.Conclusions SLC25A13 gene mutation was one of the important causes of Chinese infantal intrahepatic cholestasis. Liver biopsy, laboratory biochemistry, and blood amino acids examination were important for the diagnosis of SLC25A13 gene mutations, however, the final diagnosis must rely on gene detection.

The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia

SLC25A13 Gene Mutation in Infants with Intrahepatic Cholestasis

[SLC25A13 Gene Mutations in Chinese Infants with Intrahepatic Cholestasis and Abnormal Blood Amino Acids].

[Identification and Diagnosis of Three Novel Mutations in SLC25A13 Gene of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency].

SLC25A13 Gene Mutation Analysis in a Pedigree of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China

Clinical and Genetic Analysis of 26 Chinese Patients with Neonatal Intrahepatic Cholestasis Due to Citrin Deficiency.

[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency]

[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency].

Different regional distribution of SLC25A13 mutations in Chinese patients with neonatal intrahepatic cholestasis.

Identification of 13 Novel Mutations Including a Retrotransposal Insertion in SLC25A13 Gene and Frequency of 30 Mutations Found in Patients with Citrin Deficiency

Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD).

Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations.

Molecular Diagnosis of Pediatric Patients with Citrin Deficiency in China: SLC25A13 Mutation Spectrum and the Geographic Distribution.

Frequency and Distribution in East Asia of 12 Mutations Identified in the Slc25a13 Gene of Japanese Patients with Citrin Deficiency

Inspissated Bile Syndrome in an Infant with Citrin Deficiency and Congenital Anomalies of the Biliary Tract and Esophagus: Identification and Pathogenicity Analysis of a Novel SLC25A13 Mutation with Incomplete Penetrance.

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency: Clinical and Laboratory Investigation of 13 Subjects in Mainland of China

Overview of Citrin Deficiency:SLC25A13 Mutations and the Frequency

[Citrin Deficiency is an Important Etiology for Cholestatic Liver Disease in Children].

Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations.